Filing Details
- Accession Number:
- 0001213900-24-031700
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-09 20:49:30
- Reporting Period:
- 2024-04-05
- Accepted Time:
- 2024-04-09 20:49:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1769804 | Augmedix Inc. | AUGX | Services-Business Services, Nec (7389) | 833299164 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1826129 | Ian Shakil | C/O Augmedix, Inc. 111 Sutter Street, Suite 1300 San Francisco CA 94104 | Chief Strategy Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-04-05 | 51,387 | $4.03 | 12,217 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-04-08 | 28,563 | $0.64 | 40,780 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-04-08 | 28,563 | $3.97 | 12,217 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-08 | 9,217 | $3.97 | 3,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-04-08 | 28,563 | $0.00 | 28,563 | $0.64 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 14,356 | 2030-06-03 | No | 4 | M | Direct |
Footnotes
- This transaction was executed pursuant to a Rule 10b5-1 trading plan.
- This transaction was executed in multiple trades ranging from $3.9400 to $4.1700. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- Fully vested.
Billionaire Hedge Funds
